Cardiovascular
disease (CVD) causes significant mortality and remains
the leading cause of death globally. Thus, to reduce mortality, early
diagnosis by measurement of cardiac biomarkers and heartbeat signals
presents fundamental importance. Traditional CVD examination requires
bulky hospital instruments to conduct electrocardiography recording
and immunoassay analysis, which are both time-consuming and inconvenient.
Recently, development of biosensing technologies for rapid CVD marker
screening attracted great attention. Thanks to the advancement in
nanotechnology and bioelectronics, novel biosensor platforms are developed
to achieve rapid detection, accurate quantification, and continuous
monitoring throughout disease progression. A variety of sensing methodologies
using chemical, electrochemical, optical, and electromechanical means
are explored. This review first discusses the prevalence and common
categories of CVD. Then, heartbeat signals and cardiac blood-based
biomarkers that are widely employed in clinic, as well as their utilizations
for disease prognosis, are summarized. Emerging CVD wearable and implantable
biosensors and monitoring bioelectronics, allowing these cardiac markers
to be continuously measured are introduced. Finally, comparisons of
the pros and cons of these biosensing devices along with perspectives
on future CVD biosensor research are presented.